Delivery Order SPE2DB20D2104-SPE2DB24FQ79Q
Award Date
10/18/23
Potential Completion Date
10/19/23
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,037.49 firm fixed-price delivery order is for the supply of 4,566,825,872 units of the drug Nateglinide 120 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,023.68 firm fixed price delivery order covers the supply of 4,557,680,329 units of the medication Nateglinide 60 mg Tablet, with a completion date of June 30, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,216.66 firm fixed-price delivery order is for the supply of 4,562,449,360 Nateglinide 60 mg tablets. The award has an ultimate completion date of October 12, 2023 and was made on October 11, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order for the supply of 4,567,074 units of Nateglinide 120 mg tablets to the agency. The contract has a total ceiling value of $15,880.84 and is a firm fixed-price arrangement. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $3,372.95 for the supply of 4564766054 NATEGLINIDE 60 MG TABLET UD 30S. The contract has a firm-fixed price pricing type and an ultimate completion date of June 3, 2024. Amerisourcebergen is a for-profit corporate entity that specializes in distributing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,777.55 firm fixed-price delivery order is for the provision of 4566778208 DAPAGLIFLOZIN 10 MG TABLET 30S, an oral medication used in the management of type 2 diabetes. The contract has an ultimate completion date of December 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,204.31 firm fixed-price delivery order is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used for diabetes management. The contract has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,899.44 firm-fixed-price delivery order is for the supply of 500 tablets of 30 mg Pioglitazone HCl, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $6,450.70 and issued by the Defense Logistics Agency (DLA). The contract is for the delivery of the pharmaceutical product Dapagliflozin 5 mg Tablet, a medication used to treat type 2 diabetes. The order has a firm fixed-price pricing type and an ultimate completion date of September 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,048.05 Firm Fixed Price Delivery Order is for the supply of 4565911283 Dapagliflozin 10 mg tablets, a medication used in the management of diabetes. The contract has an ultimate completion date of September 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...